Cargando…
Mapping pathogenic processes contributing to neurodegeneration in Drosophila models of Alzheimer's disease
Alzheimer's disease (AD) is the most common form of dementia, affecting millions of people and currently lacking available disease‐modifying treatments. Appropriate disease models are necessary to investigate disease mechanisms and potential treatments. Drosophila melanogaster models of AD incl...
Autores principales: | Bergkvist, Liza, Du, Zhen, Elovsson, Greta, Appelqvist, Hanna, Itzhaki, Laura S., Kumita, Janet R., Kågedal, Katarina, Brorsson, Ann‐Christin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050262/ https://www.ncbi.nlm.nih.gov/pubmed/31823504 http://dx.doi.org/10.1002/2211-5463.12773 |
Ejemplares similares
-
Exploring Aβ Proteotoxicity and Therapeutic Candidates Using Drosophila melanogaster
por: Elovsson, Greta, et al.
Publicado: (2021) -
AβPP processing results in greater toxicity per amount of Aβ(1-42) than individually expressed and secreted Aβ(1-42) in Drosophila melanogaster
por: Bergkvist, Liza, et al.
Publicado: (2016) -
Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster
por: Sandin, Linnea, et al.
Publicado: (2016) -
Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme
por: Bergkvist, Liza, et al.
Publicado: (2020) -
Serum Amyloid P Component Ameliorates Neurological Damage Caused by Expressing a Lysozyme Variant in the Central Nervous System of Drosophila melanogaster
por: Helmfors, Linda, et al.
Publicado: (2016)